NCT00077688 - TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

September 30, 2007

Conditions

Bladder NeoplasmsUreteral NeoplasmsUrethral NeoplasmsCarcinoma, Transitional Cell

Interventions

DRUG

TOCOSOL Paclitaxel

Trial Locations (3)

University of Maryland Medical Center/Greenbaum Cancer Center, Baltimore

Cleveland Clinic Foundation, Cleveland

University of Washington/Seattle Cancer Care Alliance, Seattle